Raymond James Financial
AMED

Raymond James Financial’s Amedisys AMED Stock Holding History

Raymond James Financial’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,898
Closed -$384K – 5023
2025
Q2 		$384K Buy
+3,898
New +$369K ﹤0.01% 4155
2025
Q1 		– Sell
-2,372
Closed -$215K – 4815
2024
Q4 		$215K Buy
+2,372
New +$218K ﹤0.01% 4370

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Raymond James Financial's AMED Position: Q3 2025 in Review

Raymond James Financial sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,898 shares — an estimated $384K sold.

Raymond James Financial first reported a position in AMED in Q4 2024 and held it in 2 quarters. The position peaked at $384K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Raymond James Financial reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 3,898 Amedisys shares in Q3 2025, an estimated $384K.
  • Raymond James Financial first reported a position in Amedisys in Q4 2024 and held it in 2 quarters.
  • Raymond James Financial's Amedisys position peaked at $384K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.